Dorra Pharma Group

Dorrapharma is engaged in R&D, manufacture and market of intermediates, APIs (Active Pharmaceutical Ingredients) and formulations. We stick to raising the value both for the company and customers, and strive for creating more valuable product for the health of the life. The therapeutic areas cover anti-infection, cardiovascular, digestive system, antithrombotics and etc. Dorra always adheres to the independent R&D-powered business policy, assured with production, market and quality. We own the core technology advantage in the professional area of bromination, enzyme/metal-catalyzed, nitration and hydrogenation, and obtain multiple core patents for invention. R&D center is located in Taizhou industrial park with square meters and dedicated to the research of new compound innovation and the development of the safe, environmental friendly and highly efficient synthesis process. The manufacturing sites are approved by China GMP, ISO9001, EU authorities, FDA, Japan PMDA, etc. We are consecutive to concern about the public and repay the society with strong responsibility and social mission along with the healthy and steady development of our company. With the mission of "creating more valuable products for life and health", we are committed to fulfill our social responsibility as an excellent enterprise. Welcome to visit for details!